When is copper testing indicated?

When to Test for Copper

Test for copper when evaluating unexplained liver disease, neurological symptoms (especially movement disorders), psychiatric manifestations, hemolytic anemia, or when screening first-degree relatives of Wilson's disease patients. 1

Primary Clinical Scenarios Requiring Copper Testing

Hepatic Presentations

• Unexplained elevated transaminases in children, adolescents, or young adults
• Acute liver failure of unclear etiology (copper may be markedly elevated due to sudden release from liver stores) 1
• Chronic hepatitis without clear viral, autoimmune, or metabolic cause
• Cirrhosis in patients under 40 years old

Neurological and Psychiatric Presentations

• Movement disorders: tremor, dystonia, parkinsonism, chorea
• Psychiatric symptoms: depression, personality changes, psychosis
• Cognitive decline in young patients
• Myeloneuropathy (can indicate copper deficiency rather than Wilson's disease) 2

Hematological Presentations

• Hemolytic anemia, particularly Coombs-negative
• Unexplained cytopenias 2

Family Screening

• All first-degree relatives of confirmed Wilson's disease patients require screening 1

Comprehensive Copper Testing Panel

When Wilson's disease is suspected, order the following tests simultaneously:

Serum Tests

• Serum ceruloplasmin: Low in most Wilson's disease patients, but 15-36% of children with Wilson's disease have normal levels 1
• Total serum copper: Usually decreased in Wilson's disease (paradoxically, despite copper overload), but may be normal or elevated in acute liver failure 1
• Calculate non-ceruloplasmin-bound ("free") copper: (Total serum copper in µg/L) - (3.15 × ceruloplasmin in mg/L)
  • Elevated above 200 µg/L in most untreated Wilson's disease patients 1
  • More useful for monitoring treatment than diagnosis 1

Urinary Copper

• 24-hour urinary copper excretion (ensure complete collection with accurate volume and creatinine measurement):
  • >1.6 µmol/24h (>100 µg/24h): diagnostic of Wilson's disease in symptomatic patients 1
  • >0.64 µmol/24h: suggestive in asymptomatic children 1
  • >0.6 µmol/24h (>40 µg/24h): warrants further investigation 3
  • Note: 16-23% of Wilson's disease patients may have values <1.6 µmol/24h, especially children and asymptomatic siblings 1

Hepatic Copper Measurement

• Liver biopsy with quantitative copper determination: The gold standard
  • ≥250 µg/g dry weight: traditionally diagnostic, though 17% of Wilson's disease patients may have lower values 4
  • ≥75 µg/g dry weight: increases sensitivity to 96.5% but decreases specificity to 95.4% 4
  • Recent pediatric data supports ≥250 µg/g as reliable in children when combined with ceruloplasmin and clinical context 5
  • Requires at least 1 cm biopsy core, placed dry in copper-free container 1

Important Caveats and Pitfalls

When Ceruloplasmin Alone is Insufficient

• Normal ceruloplasmin does NOT exclude Wilson's disease: 15-36% of pediatric cases have normal levels 1
• Ceruloplasmin is an acute phase reactant and may be falsely elevated during inflammation
• Aceruloplasminemia (different genetic condition) causes absent ceruloplasmin without copper accumulation 1

Conditions That Mimic Wilson's Disease Copper Parameters

• Acute liver failure of any cause: can elevate urinary copper and serum copper 1
• Chronic cholestasis: may elevate hepatic copper and urinary copper 1
• Autoimmune hepatitis: may have urinary copper 100-200 µg/24h 3
• Heterozygote carriers: may have intermediate values but do not reach diagnostic thresholds 6

D-Penicillamine Challenge Test

• Only validated in children: 500 mg at 0 and 12 hours during 24-hour collection
• >25 µmol/24h (>1600 µg/24h): suggests Wilson's disease 1, 3
• Not recommended in adults due to lack of standardization 1
• Sensitivity only 12.5% compared to other liver diseases; unreliable for excluding diagnosis in asymptomatic siblings 1
• Heterozygotes do not reach diagnostic threshold 6

Testing for Copper Deficiency vs. Toxicity

When low serum copper is found, distinguish between:

• Copper deficiency: causes myeloneuropathy and hematological abnormalities, often from malabsorption or gastric surgery 2
• Wilson's disease: low serum copper with tissue copper overload
• Carrier state or aceruloplasminemia: also present with low serum copper 2

Algorithmic Approach to Copper Testing

1. Initial screening in suspected cases: Serum ceruloplasmin + 24-hour urinary copper
2. If ceruloplasmin low AND urinary copper >1.6 µmol/24h: Strong evidence for Wilson's disease
3. If ceruloplasmin normal but clinical suspicion high: Proceed with calculated free copper and consider liver biopsy
4. If urinary copper borderline (0.6-1.6 µmol/24h): Calculate free copper; consider liver biopsy
5. For definitive diagnosis: Liver biopsy with quantitative copper (≥250 µg/g in combination with clinical/biochemical findings) 5
6. Slit-lamp examination for Kayser-Fleischer rings should accompany all copper testing in suspected Wilson's disease

The diagnosis of Wilson's disease requires integration of multiple parameters rather than reliance on any single test, as no test alone has perfect sensitivity and specificity 4.